معرفی
Dr. Mary Lou Chatterton is a Senior Research Fellow and Co-Program Lead for Mental Health at the Health Economics Group, School of Public Health and Preventive Medicine, Monash University. She is also affiliated with the Monash University Clinical Trials Centre and actively contributes to national and international research initiatives in health economics and mental health policy.
Her research focuses on the economic evaluation of pharmacological and psychological interventions for mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. She specializes in pharmacoeconomics, cost-effectiveness analysis, and trial-based economic evaluations, with a strong emphasis on translating research into health policy. Her work supports the UN Sustainable Development Goals, particularly in promoting mental well-being and equitable healthcare access.
The recent publications highlight a consistent trend in evaluating innovative treatments—such as ketamine for depression, digital mental health tools, and CBD for alcohol use disorder—through rigorous economic modeling and clinical trial data. Her research spans preventive strategies, service delivery models like telehealth, and large-scale program evaluations, demonstrating a multidisciplinary approach to improving mental health outcomes.
Scientific Awards:
- Australian Clinical Trials Alliance HEAT Excellence in Trial Based Health Economics Award (2023)
Dr. Chatterton has supervised and mentored numerous early-career researchers and is currently accepting PhD students. She has secured significant research funding through competitive grants and collaborative projects with institutions like the University of Queensland and government bodies such as the Department of Health and Aged Care. Her leadership as Chief Investigator in multiple active projects underscores her role in shaping evidence-based mental health policy.
She is a key member of several research teams, including the KADS study team and the Head to Health evaluation consortium, working closely with clinicians, economists, and policymakers to advance mental health service delivery and economic evaluation methodologies.
